Xinjiang Tianshan Animal Husbandry Bio-Engineering Co 300313.SZ · CNY
Health Care · Shenzhen · 🇨🇳 China
11.51
+0.79%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Xinjiang Tianshan Animal Husbandry Bio-Engineering Co
Its shares trade on Shenzhen under the ticker 300313.SZ. It has been listed since 25 April 2012. In the fiscal year to 31 December 2025, it reported revenue of CN¥200.3m and a net loss of CN¥27.2m. At that date it held total assets of CN¥279.6m and shareholders' equity of CN¥31.6m.
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. engages in the cattle-breeding improvement business. The company is headquartered in Changji, Xinjiang. The company went IPO on 2012-04-25. The firm's main products include high-quality bull semen, breeding sheep, lambs and sheep semen. Through its subsidiaries, the Company is also involved in the fattening and slaughtering of livestock, the production, processing and sale of beef and mutton products, as well as land leasing and forage planting businesses. The firm distributes its products mainly in domestic market, with Northwest China as its main market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 25 Apr 2012
- Employees
- 107
- Website
- xjtssw.com ↗
Leadership
Pay as last reported
- Mr. Jianjun GeGeneral Manager
- Mr. Minghui HanDeputy General Manager, Secretary of the Board, Director, since 2022
- Mr. Qiang LiDirector
- Ms. Chao GaoIndependent Director
- Mr. Xinzhong WuIndependent DirectorCN¥40,000
- Mr. Youmin ZhangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Xinjiang Tianshan Animal Husbandry Bio-Engineering Co Ltd focuses on high-quality bull semen and breeding sheep in Northwest China.
- The company employs 107 full-time staff and operates in the Health Care sector with biotechnology expertise.
- Its main products include breeding sheep, lambs, and sheep semen distributed across domestic markets.
Weaknesses
- The company's main market is limited to Northwest China, restricting broader market reach.
- It relies on domestic market distribution without significant international presence.
- The firm's business is concentrated in cattle-breeding improvement with limited diversification.
Opportunities
- Expanding into beef and mutton processing and sale could leverage existing livestock operations.
- Land leasing and forage planting businesses offer potential for growth in agricultural services.
- The Health Care sector's biotechnology focus aligns with growing demand for advanced animal husbandry solutions.
Threats
- Dependence on the domestic market exposes the company to regional economic fluctuations.
- Limited international presence may hinder growth in global biotechnology markets.
- The company's reliance on cattle-breeding improvement could face competition from other sectors.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.